Subsequently, to further validate the expression levels and the diagnostic performance of the exosomal protein markers identified in this study, including MUC5B, SELL and APOH, we included 110 LC patients and 25 HC as a validation cohort. This evidence concerns the gene MUC5B and laryngotracheoesophageal cleft.